Planta Med 2009; 75(5): 508-511
DOI: 10.1055/s-0029-1185319
Pharmacology
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Antinociceptive Effect and GC/MS Analysis of Rosmarinus officinalis L. Essential Oil from its Aerial Parts

Ana L. Martínez1 , 2 , Maria Eva González-Trujano1 , 3 , Francisco Pellicer1 , Francisco J. López-Muñoz2 , Andrés Navarrete3
  • 1Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, México, D. F., México
  • 2Departamento de Farmacobiología del Cinvestav-Sede Sur, México D. F.
  • 3Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, México D. F., México
Weitere Informationen

Publikationsverlauf

received July 8, 2008 revised November 24, 2008

accepted December 7, 2008

Publikationsdatum:
30. Januar 2009 (online)

Abstract

The rationale of this investigation was to examine the antinociceptive properties of the essential oil obtained from Rosmarinus officinalis aerial parts, using a rat model of arthritic pain. The essential oil (100, 300 and 600 mg/kg, i. p.) produced a dose-dependent antinociceptive effect, manifested as a significant reduction in the dysfunction in the pain-induced functional impairment model in the rat (PIFIR model), mainly at high doses. Chemical constituents of the essential oil were further analyzed by gas chromatography-mass spectrometry (GC/MS). The major compounds in the essential oil were α-pinene (14.10 %), camphene (11.47 %), β-pinene (12.02 %), myrcene (3.31 %), α-phellandrene (7.87 %), eucalyptol (8.58 %), 2-bornanone (3.42 %), camphor (8.75 %), isoborneol (3.48 %), borneol (4.85 %) and borneol acetate (6.49 %). The antinociceptive effects of R. officinalis essential oil were tested in combination with 0.12 mg/kg WAY100635, s. c. (an antagonist of 5-HT1A receptors) or 1 mg/kg naloxone, i. p. (an antagonist of endogenous opioids receptors), demonstrating in both cases an inhibition of the antinociceptive response. This study suggests an involvement, at least in part, of the serotonergic system via 5-HT1A receptors and endogenous opioids in the antinociceptive effect of R. officinalis essential oil in the PIFIR model.

References

  • 1 Kim M J, Nam E S, Paik S I. The effects of aromatherapy on pain, depression, and life satisfaction of arthritis patients.  Taehan Kanho Hakhoe Chi. 2005;  35 186-194
  • 2 Gedney J J, Glover T L, Fillingim R B. Sensory and affective pain discrimination after inhalation of essential oils.  Psychosom Med. 2004;  66 599-606
  • 3 Santoyo S, Cavero S, Jaime L, Ibañez E, Señoráns F J, Reglero G. Chemical composition and antimicrobial activity of Rosmarinus officinalis L. essential oil obtained via supercritical fluid extraction.  J Food Prot. 2005;  68 790-795
  • 4 González-Trujano M E, Peña E I, Martínez A L, Guevara-Fefer P, Moreno J, Déciga-Campos M, López-Munñoz F J. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents.  J Ethnopharmacol. 2007;  111 476-482
  • 5 López-Muñoz F J, Salazar L A, Castañeda-Hernández G, Villarreal J E. A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR).  Drug Dev Res. 1993;  28 169-175
  • 6 Lukaczer D, Darland G, Tripp M, Liska D, Lerman R H, Schiltz B, Bland J S. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia.  Phytother Res. 2005;  19 864-869
  • 7 Tung Y T, Chua M T, Wang S Y, Chang S T. Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs.  Bioresources Technol. 2008;  99 3908-3913
  • 8 Chao L K, Hua K F, Hsu H Y, Cheng S S, Liu J Y, Chang S T. Study on the anti-inflammatory activity of essential oil from leaves of Cinnamomum osmophloeum.  J Agric Food Chem. 2005;  53 7274-7278
  • 9 Lee H J, Hyun E A, Yoon W J, Kim B H, Rhee M H, Kang H K, Cho J Y, Yoo E S. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts.  J Ethnopharmacol. 2006;  103 208-216
  • 10 Menezes I A, Marques M S, Santos T C, Dias K S, Silva A B, Mello I C, Lisboa A C, Alves P B, Cavalcanti S C, Marçal R M, Antoniolli A R. Antinociceptive effect and acute toxicity of the essential oil of Hyptis fruticosa in mice.  Fitoterapia. 2007;  78 92-95
  • 11 Aydin S, Demir T, Oztürk Y, Başer K H. Analgesic activity of Nepeta italica L.  Phytother Res. 1999;  13 20-23
  • 12 Liapi C, Anifandis G, Chinou I, Kourounakis A P, Theodosopoulos S, Galanopoulou P. Antinociceptive properties of 1,8-cineole and beta-pinene, from the essential oil of Eucalyptus camaldulensis leaves, in rodents.  Planta Med. 2007;  73 1247-1254
  • 13 Rao V S, Menezes A M, Viana G S. Effect of myrcene on nociception in mice.  J Pharm Pharmacol. 1990;  42 877-878
  • 14 Sousa O V, Silvério M S, Del-Vechio-Vieira G, Matheus F C, Yamamoto C H, Alves M S. Antinociceptive and anti-inflammatory effects of the essential oil from Eremanthus erythropappus leaves.  J Pharm Pharmacol. 2008;  60 771-777
  • 15 Santos F A, Rao V S. Antiinflammatory and antinociceptive effects of 1,8-cineole a terpenoid oxide present in many plant essential oils.  Phytother Res. 2000;  14 240-244
  • 16 Juergens U R, Engelen T, Racké K, Stöber M, Gillissen A, Vetter H. Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes.  Pulm Pharmacol Ther. 2004;  17 281-287
  • 17 Macpherson L J, Hwang S W, Miyamoto T, Dubin A E, Patapoutian A, Story G M. More than cool: promiscuous relationships of menthol and other sensory compounds.  Mol Cell Neurosci. 2006;  32 335-343
  • 18 Bang S, Kim K Y, Yoo S, Kim Y G, Hwang S W. Transient receptor potential A1 mediates acetaldehyde-evoked pain sensation.  Eur J Neurosci. 2007;  26 2516-2523
  • 19 Hall A C, Turcotte C M, Betts B A, Yeung W Y, Agyeman A S, Burk L A. Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids.  Eur J Pharmacol. 2004;  506 9-16
  • 20 Zimmermann M. The guidelines on ethical standards for investigation of experimental pain in animals.  Pain. 1983;  16 109-110

Dra. Ma. Eva González Trujano

Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”
Calz. México-Xochimilco

101 Col. Sn Lorenzo Huipulco

14370, México

D. F. México

Telefon: + 52 55 56 55 28 11

Fax: + 52 55 56 55 99 80

eMail: evag@imp.edu.mx